anti-EpCAM/anti-CD3 bispecific antibody M701
Term · Oncology and biomedicine · MLC-T-ONC-010637
A human-mouse chimeric bispecific antibody directed against both CD3 and epithelial cell adhesion molecule (EpCAM), with potential immunomodulating and antineoplastic activities. Upon administration, anti-EpCAM/anti-CD3 bispecific antibody M701 binds to both CD3 on cytotoxic T lymphocytes (CTLs) and EpCAM on EpCAM-expressing tumor cells. This activates and redirects CTLs to EpCAM-expressing tumor cells, which results in the CTL-mediated cell death of EpCAM-expressing tumor cells. EpCAM, a cell surface protein upregulated on many tumor cell types, promotes the proliferation, migration and invasiveness of tumor cells.
| Identifier | MLC-T-ONC-010637 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | EpCAM x CD3 bispecific antibody M701 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-010637",
"term": "anti-EpCAM/anti-CD3 bispecific antibody M701",
"field": "Oncology and biomedicine",
"definition": "A human-mouse chimeric bispecific antibody directed against both CD3 and epithelial cell adhesion molecule (EpCAM), with potential immunomodulating and antineoplastic activities. Upon administration, anti-EpCAM/anti-CD3 bispecific antibody M701 binds to both CD3 on cytotoxic T lymphocytes (CTLs) and EpCAM on EpCAM-expressing tumor cells. This activates and redirects CTLs to EpCAM-expressing tumor cells, which results in the CTL-mediated cell death of EpCAM-expressing tumor cells. EpCAM, a cell surface protein upregulated on many tumor cell types, promotes the proliferation, migration and invasiveness of tumor cells.",
"synonyms": [
"EpCAM x CD3 bispecific antibody M701"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anti-epcam-anti-cd3-bispecific-antibody-m701/"
}
Record 1,734 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.